BSc3094
BSc3094 is a Tau aggregation inhibitor. BSc3094 can be used for the research of Alzheimer's disease (AD) [1].
Product Specifications
CAS Number
[946857-84-7]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Tau Protein
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bsc3094.html
Purity
98.86
Solubility
DMSO : 33.33 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=C2N=CNC2=C1)NNC3=NC(C4=CC=C([N+]([O-])=O)C=C4)=CS3
Molecular Formula
C17H12N6O3S
Molecular Weight
380.38
Precautions
H302, H315, H319, H335
References & Citations
[1]Anglada-Huguet M, et al. Inhibition of Tau aggregation with BSc3094 reduces Tau and decreases cognitive deficits in rTg4510 mice. Alzheimers Dement (N Y) . 2021;7 (1) :e12170. Published 2021 Jun 1.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS638238-01 0.02 mg
DEP1 (1024-1306), protein tyrosine phosphatase, catalytic domain, Recombinant, Human (Density-enhanced Phosphatase-1, PTP-eta, CD148)
Ask
View Details 
MBS638238-02 5x 0.02 mg
DEP1 (1024-1306), protein tyrosine phosphatase, catalytic domain, Recombinant, Human (Density-enhanced Phosphatase-1, PTP-eta, CD148)
Ask
View Details